Relieved of ‘high-risk’ marker, New Horizon Health aims to break even next year
Encouraged by its fast-growing revenue last year, the cancer screening device maker believes its losses may end in 2023 Key Takeaways: New Horizon Health is expected to attract more investors…
6606.HK
Recent Articles
RELATED ARTICLES
-
New Horizon Health finds formula for profits ahead of schedule
6606.HK
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
-
Burning Rock narrows losses with drug research as new driver
BNR.US
- CHINA BULLETIN: Six New BRICS
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
-
Sales success comes with side effects for drug maker BeiGene
BGNE.US 6160.HK
-
Heated market for dueling blood cancer drugs lands BeiGene in court
BGNE.US 6160.HK
Discover hidden China stock gems in our weekly newsletter